Greene Biotech (301688.SZ), which has been deeply involved in the fragrance field for more than 20 years, plans to publicly issue 333.333.4 million shares

According to the Zhitong Finance App, Gelin Biotech (301688.SZ) disclosed a prospectus. The number of shares the company plans to publicly issue is 33333.34 million shares, accounting for 25.00% of the total number of shares of the company after this public offering. The current public offering of shares used the company's public offering of new shares, and the original shareholders did not publicly sell their shares. The initial inquiry date for this offering is August 14, 2026, and the subscription date is August 20, 2026. The company will apply for listing on the GEM as soon as the distribution is over.

The initial number of strategic placements issued in this offering was 10 million shares, accounting for 30.00% of the current offering. Among them, the estimated number of subscriptions for the special asset management plan set up by the company's senior management and core employees participating in this strategic placement does not exceed 10.00% of the current issuance amount, that is, no more than 3,333.33 million shares, and the subscription amount is not more than 69 million yuan; the initial follow-up amount of the sponsor's related subsidiaries is 1,666.66 million shares, accounting for 5.00% of the current issuance; other investors participating in the strategic placement expect the total subscription amount not to exceed 85 million yuan.

The company has been deeply involved in the fragrance field for more than 20 years and is one of the pioneers and important well-known enterprises in the fragrance industry in China. Since its establishment, the company has focused on R&D, production and sales of fragrance products, forming three major product lines: turpentine oil, cedar oil, and full synthesis. The specific products mainly include nearly 40 subvarieties such as sandalwood series, methyl cedar ketone, and turpentine series. The company's products are mainly used downstream as raw materials for the formulation of daily chemical essences. They are widely used in the fields of washing, cleaning, disinfection and personal care products, and have broad downstream market demand space.

The company achieved net profit attributable to the owners of the parent company from 2023 to 2025:929.241 million yuan, 150 million yuan and 179 million yuan, respectively. From January to June 2026, the company's revenue was 608 million yuan, up 11.07% from the same period last year. Net profit attributable to shareholders of the parent company was 98.5212 million yuan, up 4.17% from the same period last year. Net profit attributable to shareholders of the parent company after deducting non-recurring profit and loss was 96.8444 million yuan, up 3.79% from the same period last year, mainly due to the company's increased market development efforts and sales scale.

After deducting issuance costs, the company will mainly invest in projects such as “production of advanced spices with an annual output of 6,300 tons”, “intelligent transformation of factory facilities”, and “R&D, innovation, transformation and upgrading”. In total, it plans to use the raised capital of 690 million yuan.